The world-wide impact of traumatic injury and associated hemorrhage on human health and well-being cannot be overstated. Twelve percent of the global disease burden is the result of violence or accidental injury. Hemorrhage is responsible for 30 to 40% of trauma mortality, and of these deaths, 33 to 56% occur during the prehospital period. Among those who reach care, early mortality is caused by continued hemorrhage, coagulopathy, and incomplete resuscitation. The techniques of early care, including blood transfusion, may underlie late mortality and long-term morbidity. While the volume of blood lost cannot be measured, physiologic and chemical measures and the number of units of blood given are readily recorded and analyzed. Improvements in early hemorrhage control and resuscitation and the prevention and aggressive treatment of coagulopathy appear to have the greatest potential to improve outcomes in severely injured trauma patients.
1
Violence-self-inflicted, interpersonal, and war-related-accounts for half of trauma mortality, with 1.6 million deaths in the year 2000. Road traffic accounts for the next largest proportion, roughly 1.2 million deaths, per year, 2.1% of overall mortality. An additional 20 to 50 million people are injured annually in road traffic incidents. 2, 3 Though most of the world's trauma mortality occurs in developing countries, trauma is a significant cause of morbidity and mortality in industrialized nations as well. In the United States in 2003, over 29 million people, more than 10% of the population, suffered nonfatal injuries. Injury was the third leading cause of death overall and the leading cause of death among those aged 1 to 44 years. In the U.S., nearly 30% of years of potential life lost before age 65 results from traumatic injury, the largest contribution of any cause of death and nearly twice that of the next leading cause, cancer. 4 The direct economic burden of trauma care is also considerable. The youth of the affected population and the potential chronicity of disease and complications contribute greatly to the resulting social and economic burdens. A number of studies have documented the lasting impact of traumarelated morbidity and its effect on quality-of-life, [5] [6] [7] and the WHO estimates that nations can spend up to 2% of their gross domestic product caring for patients injured as the result of road traffic incidents alone. 1 The Centers for Disease Control and Prevention estimate that in the U.S. $117 billion was spent on medical care for injuries in the year 2000, representing approximately 10% of national health care spending. 8 The economic burden of trauma is also felt indirectly as lost work hours and productivity among injured patients and their caregivers. A regional study of trauma patient recovery conducted 18 months following hospital discharge revealed a 16% decrease in a standard measurement of functional wellbeing among trauma patients with a mean Injury Severity Score (ISS) of 13. 5 In a recent 24 month follow-up study of German multi-system trauma victims with mean ISS of 23 conducted by one of the authors (RL), the return-to-work rate was only 50%. A similar study in Spain revealed a return-towork rate of 58% at two years. 
The Epidemiology of Hemorrhage in Trauma
Independent of the mechanism of injury, hemorrhagic shock consistently represents the second-leading cause of early deaths among the injured, with only central nervous Severe CNS injury is devastating and has a high rate of prehospital mortality; and there are few interventions offering hope for survival and functional recovery. 16 In contrast, hemorrhage and hemorrhagic shock, which account for 30 to 40% of trauma deaths, are more amenable to interventions to reduce mortality and morbidity. Furthermore, about 25% of CNS injuries are complicated by shock. 15, 17 Among those with multiple injuries, brain injury remains the primary cause of death, but hypotension increases mortality in this group two-to three-fold. 17, 18 The significant contribution of hemorrhagic shock to brain injury mortality further illustrates the role of hemorrhage control in reducing traumatic mortality.
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Early Mortality
The majority of trauma deaths occur in the first few hours following injury, often before the injured patient reaches a hospital (Fig. 1) . 9, 13, 15 Hemorrhage contributes to death during the prehospital period in 33 to 56% of cases, and exsanguination is the most common cause of death among those found dead upon the arrival of emergency medical services (EMS) personnel. 13 Hemorrhage accounts for the largest proportion of mortality occurring within the first hour of trauma center care, over 80% of operating room deaths after major trauma, and almost 50% of deaths in the first 24 hours of trauma care. 9, 12, 13 After the first hours of trauma center care, CNS injury replaces hemorrhage as the leading cause of trauma mortality. Very few hemorrhagic deaths occur after the first day.
9,13
Late Mortality and Morbidity
Early hypotension as a marker for late mortality
The presence of hemorrhagic shock is a predictor of poor outcome in the trauma patient, and the volume of hemorrhage is tied to outcome. As the amount of blood loss increases, so do resuscitation requirements and physiologic derangements including hypotension and acidosis. The volume of blood lost has proven impossible to reconstruct, but blood pressure and the number of blood units replaced are readily measured.
Hypotension noted in the field or upon initial hospital evaluation is associated not only with late mortality but also specifically with the development of eventual complications including multiple organ failure (MOF) and infections such as pneumonia and sepsis. 19, 20 The presence of early hemorrhagic shock as defined by a systolic blood pressure less than or equal to 90 mm Hg in the pre-hospital setting or emergency department is associated with high rates of organ failure (24%) and infection (39%). Early acidosis, measured as base deficit in the first hour of admission, is associated with significant hemorrhage, injury severity and hypotension. 21 Early and overall red blood cell transfusion requirements increase with increasing base deficit from a mean of 2.6 units (1.4 in the first 24 hours) in patients with mild base deficits (Ϫ3 to Ϫ5) to 9.7 units (8.3 in the first 24 hours) in patients with severe base deficits (ՅϪ10). Base deficit also predicts the development of coagulopathy, organ failure, and mortality. Patients with mild base deficits have survival rates near those of patients without acidosis (89% versus 94%), while those with severe acidosis have a nearly 50% mortality rate. 
Multi-organ Failure
Not surprisingly, trauma patients die more often of the immediately uncontrollable consequences of their injuries than of late sequelae. 9, 10, 13, 15 Delayed death is also most often due to complications developing during care rather than directly to the injuries themselves.
9,10,13 Multiple organ failure, the synchronous derangement of more than one critical organ system, is the leading cause of morbidity and mortality in the trauma intensive care unit (ICU). 22 The incidence of MOF following injury occurs in a bimodal pattern, with an initial peak within the first three days of hospitalization, and a second between 5 and 7 days. 23, 24 The combined impact of this delayed mortality is 7 to 9%. The mortality rate for patients who develop organ failure is directly related to the number of involved organ systems and can exceed 50% overall, reaching over 80% fatality with four involved systems. 23, 25 Despite differences among sources in the definition of failure for individual organ systems, the incidence of MOF following major trauma does appear to have decreased over the past 15 years (Fig. 2) . 26 In the early 1990's, among trauma patients with injury severity scores (ISS) 19 -25, mortality was reported at 13 to 15%, while by the latter part of the decade, mortality had decreased to 5%. [23] [24] [25] A recently published, prospective, 12-year single-center study of MOF in trauma patients with a mean ISS of 29 reported nearly half the incidence of MOF in 2003 than in 1992 despite increasing injury severity over the same period. 26 Despite the apparently decreasing incidence of MOF, however, the proportion of trauma patients with MOF listed as the cause of death remained essentially unchanged; 7% in the early 1990's and 9% later in the decade. 13, 15 Similarly, throughout the follow-up period, essentially half of all trauma patients diagnosed with MOF died.
23,25
Sepsis
Contaminated and devitalized tissue leading to postinjury derangement of immune function puts trauma patients at high risk for sepsis. The inflammatory modulation and resulting derangement of immunity induced by hemorrhagic shock is similar to that seen in sepsis and MOF and is likely mediated through the activity of similar cytokines and pathways. 27 The statistical association of massive transfusion for hemorrhagic shock with the development of MOF and with overall mortality may also be a reflection of immuno-modulation but this link has not yet been fully elucidated. 23, 25, 28, 29 
Clinical Presentations in Trauma Hemorrhage
Causes of injury
Patients who present with penetrating wounds to the thorax and abdomen are at risk for severe injuries to major vessels, and therefore for massive hemorrhage, and are most likely to die during the acute phase of care. 9, 13 For these patients, rapid identification and control of hemorrhage is paramount, and they often require immediate surgery, especially if they are in shock. 19 The difference in severity of hemorrhage from vascular injuries caused by blunt and penetrating mechanisms is unclear. Major hemorrhage from penetrating injuries is frequently not difficult to localize; however the diagnosis of the source of even severe bleeding in blunt trauma can be more challenging. In the patient with blunt trauma, the localization of hemorrhage frequently requires specialized diagnostic procedures such as computed tomography, ultrasound, and angiography to optimally control bleeding.
Causes of Shock
Hypovolemia from hemorrhage is the most common cause of shock in the trauma patient but not the only possible cause. High spinal cord injuries can cause hypotension, so-called neurogenic shock. Myocardial contusion, as well as intrinsic dysfunctional states such as myocardial infarction or heart failure, can cause cardiogenic shock. In addition, cardiovascular physi- Data adapted from Sauaia et al. 1994 , 23 Sauaia et al. 1995 , 13 Moore et al., 22 Stewart et al., 15 
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Causes of Bleeding
Direct injury
The term "surgical bleeding" is not well-defined and not particularly helpful. Traditionally, it was intended to describe vascular and tissue disruption amenable to surgical intervention, that is, direct operative visualization and suture repair. The advent of damage control surgery, interventional radiology with embolization, and novel topical hemostatic agents has blurred the utility of this definition. Regardless of precise definition, most of what has been called surgical bleeding in the past is severe and will be rapidly fatal if not controlled.
Coagulopathy
Overt coagulopathy affects at least 1 in 4 seriously injured trauma patients. 30 Etiologies include the direct effects of hemorrhage, hemodilution, hypothermia, and acidosis. The coagulopathy of trauma is directly proportional to injury severity, massive resuscitation and transfusion, and hemorrhagic shock. 30 -33 The presence of an abnormal prothrombin time (PT) on admission is associated with a tripling of the mortality rate of injured patients, and this mortality tends to occur early. 30 Irreversible bleeding due to the coagulopathy of trauma causes the largest proportion of post-operative trauma fatalities and contributes substantially to the overall mortality of trauma. 30, [32] [33] [34] [35] [36] [37] [38] Coagulopathic comorbidities such as cirrhosis and hemophilia that predispose to bleeding diatheses may also be present in trauma patients. Much more commonly however, intentional or unintentional anti-coagulation due to exogenous agents, that is, pharmaceutical anti-coagulants like warfarin or anti-platelet agents like aspirin or ethanol, 39 may complicate the coagulation capability of the trauma patient. As examples, clopidogrel (Plavix) inhibits platelet function and has been demonstrated to nearly double the red blood cell transfusion requirement in cardiac surgery while increasing the platelet requirement by a factor of almost eight. 40 Ibuprofen has been shown to increase operative blood loss by nearly 60% in hip arthroplasty. 41 Warfarin and aspirin can increase the mortality rate of traumatic brain injury four-to-five fold.
42,43
Therapeutic Considerations: Preventing Complications and Improving Outcomes
Critically injured trauma patients are treated in three, often overlapping phases: the initial control and resuscitation phase, when initial hemorrhage control and lifesaving stabilization efforts occur; the interventional phase, when definitive control of bleeding is attained; and the critical care phase, when support and restoration of normal physiology are accomplished.
Initial Control and Resuscitative Phase
Early trauma care focuses on minimizing hemorrhage and resuscitating effectively. There is no debate about the importance of hemorrhage control as a first-line measure. The optimal development and deployment of novel hemostatic agents, dressings and tourniquets are subjects of active research.
Novel Agents for Early Hemostasis
The control of bleeding and limitation of blood loss is the only means of avoiding the problems associated with massive hemorrhage in trauma. Novel methods of early hemorrhage control are under investigation. Recombinant factor VIIa (NovoSeven, Novo-Nordisk Pharmaceuticals, Inc.) has demonstrated promise in clinical series as an adjunct to traditional measures in controlling hemorrhage in acute, life-threatening traumatic coagulopathy. 44, 45 Prospective trials investigating the utility of this powerful but expensive agent in traumatic hemorrhage are ongoing. Progress is also being made in the development and testing of novel dressings and dressingadjuncts for use on externally compressible or visceral hemorrhage. The most promising of these in pre-clinical studies has been the fibrin dressing developed by the American Red Cross which has shown superior hemostatic effect in models of severe arterial (femoral and aortic) and hepatic hemorrhage. [46] [47] [48] [49] The fibrin dressing is distinguished from other available agents such as poly-N-acetyl glucosamine (chitosan and rapid deployment hemostat) bandages and granular mineral zeolite (QuickClot) in that it contains purified human fibrinogen and thrombin and thus is inherently hemostatic while other products support hemostasis primarily through adherence to and dessication of the bleeding wound, not directly through thrombogenesis.
48,50 -52
Tourniquets
Though uncommon in civilian trauma, exsanguination from traumatic extremity amputation has historically been a common cause of potentially preventable deaths from combat injuries. 53 Tourniquet use in civilian situations is controversial and has been avoided in recent years due to what appears to be primarily a theoretical fear of limb damage or loss, 54 however, military medical doctrine has adopted a liberal policy on the prehospital use of field tourniquets to prevent excessive blood loss and mortality from extremity vascular wounds.
55,56
Other New Agents and Techniques
Emerging areas of research in early hemostasis for trauma include intra-cavitary agents for non-compressible bleeding and transcutaneous high frequency ultrasound. Intra-cavitary hemostatic agents are foams that can be instilled into a closed abdominal or thoracic cavity and will expand to compress a bleeding vessel, limiting blood loss before definitive control. 57 Transcutaneous high frequency ultrasound claims to merge the utility of ultrasound for both
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the localization and control of hemorrhage by using the same ultrasound probe for the low-frequency localization of internal bleeding followed by the targeted application of high frequency sound waves to the source for coagulation of the bleeding point.
58
Resuscitation
In contrast to the obvious logic and relative uniformity of opinion on hemorrhage control, current opinion on resuscitation is not as clear. There is no argument that the hemodynamically unstable patient must be supported; however, the optimal degree and agents of that support remain unclear. In a patient whose bleeding has not been definitively controlled, resuscitation to physiologically normal blood pressure may lead to "popping the clot", that is, dislodgment of hemostatic thrombus, and further bleeding. Resuscitation to a physiologically adequate but subnormal blood pressure, so-called "hypotensive resuscitation", before definitive hemorrhage control can be attained, has been used to avoid some of the rebleeding that occurs with resuscitation to conventional degrees. 31,59 -64 However, in head injury patients, the prevention of rebleeding may be outweighed by decreased cerebral perfusion: even transient hypotension in patients with combined hemorrhage and brain injury is associated with increased mortality.
17,18
Blood Product Use in Resuscitation
Although powerfully intuitive and almost universally practiced, the use of blood products in resuscitation has not been examined by the kinds of controlled clinical trials demanded now for the introduction of new clinical care products and techniques. This is because blood transfusion and resuscitation were synonymous when the practice and the term first became generally accepted in trauma care during World War I. 65 However, the increasing number of studies questioning the long-term consequences of early massive transfusion for trauma 28, 29 make the planning and implementation of trials to try to answer some of these questions both likely and important.
Operative Phase
Approximately 50% of patients in hemorrhagic shock are taken directly from the emergency department to the operating room. 19 Because anatomically defined, so-called "surgical" bleeding, tends to be severe and can only be controlled by specialized intervention, early identification of these injuries is essential. Prompt definitive control of this kind of hemorrhage, by surgical or angiographic embolization techniques, is unarguably essential to preserve life and minimize morbidity. However, in the trauma patient who is cold and hypovolemic and becoming acidotic and coagulopathic, a "damage control" approach is now widely advocated. 66 That is, life-threatening injuries, bleeding, and contamination are addressed emergently, and then the patient is taken to the ICU for warming and continued resuscitation with the goal of restoring normal hemostatic physiology before definitive surgery is attempted.
Critical Care Phase
The critical care phase begins after definitive hemorrhage control has been attained and involves completion of resuscitation, intensive monitoring, and optimization of the physiologic milieu for injury recovery. Correction of hypothermia, coagulopathy, and resuscitation to physiologic endpoints occur in this phase. As noted earlier, hemorrhage itself is not a large problem in this phase; however the degree to which massive hemorrhage and/or the blood products used to treat life-threatening hemorrhage set the stage for the principal causes of morbidity and late mortality, that is, sepsis and MOF, are of concern and remain to be adequately explored.
Unfortunately, iatrogenic injury is a well-described cause of late morbidity and mortality in trauma patients. Infections of central venous catheters are common, causing over 40% of episodes of bacteremia in patients with organ failure and much attention has been paid to preventing these infections. 23 Adult respiratory distress syndrome (ARDS) occurs in between 70 and 80% of patients with MOF. 24 Protective ventilatory strategies in patients with ARDS have improved outcomes. 67, 68 
SUMMARY AND CONCLUSIONS
Injury is a world-wide problem with severe and farranging consequences. Much of the mortality and morbidity resulting from injury arises from hemorrhage, but many of the problems associated with severe traumatic hemorrhage are potentially solvable. Improving outcomes will require improved early hemorrhage control, resuscitation procedures, and more complete understanding of the patho-physiology of the coagulopathy of trauma, sepsis, and MOF. If the physiologic derangements of injury can be minimized with better hemorrhage control measures early in care, it seems likely that the rates of late complications and mortality will be decreased and outcomes improved.
DISCUSSION
Dr. Jeff Johnson:
The experienced trauma clinician understands that all bleeding stops. However, as Dr. Kauvar has pointed out, the demise of the patient too often precedes the cessation of bleeding. Through a series of well-thought-out experiments Carl Wiggers nicely described that the depth of shock and the duration of shock are the primary determinants of outcome. While we now have more elegant ways of describing the depth of shock and studying oxygen debt and oxygen delivery, we don't yet understand the best way to reverse shock.
I have three general questions. The first relates to the argument that limited resuscitation strategies should prevent or limit further hemorrhage. The human data for this are largely derived from a study of patients with penetrating torso injuries who are very close to definitive care of their injuries. Looking at blunt or mixed trauma populations, limited resuscitation, while apparently doing no harm, appears to be no better. In recent US military operations, with smaller units in more dispersed areas and using body armor, extremity injuries are what we're seeing. My question is: How are we going to assess the efficacy of limited resuscitation in this kind of setting? What kind of data are needed to see whether limited resuscitation is effective in an extremity injury, distant from definitive care? Further, does this concept apply to the patient with a successfully applied tourniquet or a successfully applied hemostatic bandage?
My second question relates to the "bloody vicious cycle". As the authors point out, coagulopathy, hypothermia and acidosis can doom either operative or non-operative management. My question relates to the timing of intervention. With the inherent delay in laboratory testing, are we identifying these patients quickly enough? What is the best way to predict the patient who will suffer that problem? If you had one test at the arrival of the patient to help predict that, what would it be?
Lastly, a question for the trauma surgeons in the group. Hemorrhage control is no longer just about stitches. It is a multi-disciplinary project. Should we as surgeons abdicate our role as those who are the champions of hemostasis, or shall we make sure that we are adequately trained in techniques of angio-embolization, hemorrhage control, transfusion medicine, and component therapy?
Dr. Angus Wells: I would like to make some comments about the epidemiology of trauma from a blood bank point of view. The international and national data that you used to illustrate the problem of trauma is very illuminating. We've collected population-based data on blood use in the north of England for some years now. The area has a population of about 2.9 million and we've consistently found that trauma needs 6% of our blood supply, less than the estimates for America. Yet within that, half is for fractured neck or femurs, that is, frail elderly patients who have perhaps been topped up before surgery. Hospital episode statistics for the National Health Service in England, show only 2.4% of admissions were for trauma. And within that group, only 0.28% were major or multiple trauma. Therefore I am suggesting that there is a very small group of heavily transfused trauma patients who don't use a huge amount of the blood supply but, as individuals, are a high-volume, high-risk group.
Dr. David Kauvar: Dr. Johnson asked about limited resuscitation. ISR researchers have been working on animal models of limited resuscitation or hypotensive resuscitation, and their shock models show that hypotensive resuscitation
